Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#21 / 200 Total
ONEG - OneConstruction Group Ltd - Stock Price Chart
TickerONEG [NASD]
CompanyOneConstruction Group Ltd
CountryHong Kong
IndustryEngineering & Construction
Market Cap38.22MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own0.07%
Insider Trans-Inst Trans233.33%
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume61.55K52W Range1.96 - 4.05
OneConstruction Group Ltd. is a holding company, which engages in the procurement and installation of structural steel for construction projects. It is involved in performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control. The company was founded in 2021 and is headquartered in Hong Kong.
HWH - HWH International Inc - Stock Price Chart
TickerHWH [NASD]
CompanyHWH International Inc
CountryUSA
IndustryLeisure
Market Cap10.20MEPS (ttm)-0.99
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S10.52EPS next 5Y-
P/B-EPS Q/Q13.97%
Dividend-Sales Q/Q-
Insider Own86.67%Inst Own4.57%
Insider Trans209.27%Inst Trans-
Short Float10.68%Earnings-
Analyst Recom-Target Price-
Avg Volume1.56M52W Range1.27 - 15.75
HWH International, Inc. operates as a lifestyle business through a membership model. It enables home-based people in the new GIG economy to create lasting wealth. Its segments include HWH Marketplace, Hapi Cafe, Hapi Travel Destinations, and Hapi Wealth Builder. HWH Marketplace offers discounted sale of certain products, manufactured by affiliate company, Sharing Services Global Corp., to members. Hapi Cafe offers location-based social experiences where members can build a sense of community with like-minded customers with a potential interest in the same products. Hapi Travel Destinations aims to offer exclusive access to unpublished rates and discounts on air travel, cruises, car rentals, hotels, and resorts for members. Hapi Wealth Builder is exploring options of providing services to members through educational materials and seminars aimed at various types of investing opportunities. The company is headquartered in Bethesda, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chan Heng Fai AmbroseDirectorDec 24 '24Buy0.451,300,000585,00012,687,954Dec 26 05:15 PM
Chan Heng Fai AmbroseDirectorNov 25 '24Buy0.684,411,7643,000,00011,387,954Nov 26 07:12 PM
Chan Heng Fai AmbroseChief Executive OfficerSep 24 '24Buy0.636,034,5373,801,75819,264,692Sep 26 09:39 PM
TISI - Team, Inc - Stock Price Chart
TickerTISI [NYSE]
CompanyTeam, Inc
CountryUSA
IndustrySpecialty Business Services
Market Cap78.19MEPS (ttm)-8.65
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y4.18%
P/S0.09EPS next 5Y-
P/B44.99EPS Q/Q69.37%
Dividend-Sales Q/Q-0.39%
Insider Own4.40%Inst Own50.71%
Insider Trans0.55%Inst Trans1.17%
Short Float0.68%EarningsMar 19/a
Analyst Recom-Target Price13.00
Avg Volume14.52K52W Range5.97 - 26.77
Team, Inc. engages in the provision of fully-integrated, customized solutions for specialty industrial services. It operates through the Inspection and Heat Treating (IHT) and Mechanical Services (MS) segments. The IHT segment offers non-destructive testing services primarily for the process, pipeline and power sectors, pipeline integrity management services, and field heat treating services, as well as associated engineering and condition assessment services. The MS segment refers to solutions designed to serve clients' needs during both the operational (onstream) and off-line states of assets. Its onstream services include a range of standard to custom-engineered leak repair and composite solutions, emissions control and compliance, hot tapping and line stopping, and on-line valve insertion solutions. The company was founded in 1973 and is headquartered in Sugar Land, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Horton Anthony RDirectorNov 15 '24Buy15.241,08216,4902,081Nov 18 02:24 PM
HAIGHT NELSON MChief Financial OfficerJun 21 '24Option Exercise0.008,721015,318Jun 24 04:48 PM
Corre Partners Management, LLC10% OwnerJun 14 '24Buy8.294,00033,1521,559,520Jun 17 05:47 PM
Corre Partners Management, LLC10% OwnerJun 03 '24Buy7.322,80020,4901,555,520Jun 05 05:54 PM
Corre Partners Management, LLC10% OwnerMay 21 '24Buy7.006,12242,8731,548,489May 23 05:08 PM
SKYE - Skye Bioscience Inc - Stock Price Chart
TickerSKYE [NASD, RUT]
CompanySkye Bioscience Inc
CountryUSA
IndustryBiotechnology
Market Cap68.26MEPS (ttm)-0.73
P/E-EPS this Y-64.38%
Forward P/E-EPS next Y-18.89%
PEG-EPS past 5Y42.99%
P/S-EPS next 5Y-
P/B1.02EPS Q/Q31.88%
Dividend-Sales Q/Q-
Insider Own42.09%Inst Own43.95%
Insider Trans-1.79%Inst Trans-5.46%
Short Float12.33%EarningsMar 20/a
Analyst Recom1.00Target Price17.33
Avg Volume174.89K52W Range1.83 - 17.65
Skye Bioscience, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new medicines that unlock the pharmaceutical potential of the endocannabinoid system to treat diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration. Its products include nimacimab and SBI-100 Ophthalmic Emulsion. The company was founded on March 16, 2011 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Diep Tuan TuChief Development OfficerNov 18 '24Sale4.9919,48997,25082,259Nov 20 08:23 AM
Diep Tuan TuChief Development OfficerNov 15 '24Sale5.5585472101,748Nov 20 08:23 AM
ARSENAULT KAITLYNChief Financial OfficerNov 18 '24Sale4.9943,206215,598166,342Nov 19 09:57 PM
ARSENAULT KAITLYNChief Financial OfficerNov 15 '24Sale5.551901,054209,548Nov 19 09:57 PM
DHILLON PUNITChief Executive OfficerNov 18 '24Sale4.9982,546411,905329,823Nov 19 09:20 PM
SCNX - Scienture Holdings Inc - Stock Price Chart
TickerSCNX [NASD]
CompanyScienture Holdings Inc
CountryUSA
IndustryPharmaceutical Retailers
Market Cap18.07MEPS (ttm)-23.73
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S7.41EPS next 5Y-
P/B0.20EPS Q/Q70.66%
Dividend-Sales Q/Q-96.85%
Insider Own48.62%Inst Own1.04%
Insider Trans0.00%Inst Trans48.05%
Short Float0.36%Earnings-
Analyst Recom1.00Target Price6.75
Avg Volume2.87M52W Range1.00 - 22.18
Mar-19-25 08:05AM Scienture Holdings Announces Draw on ELOC, Temporarily Suspends Further Draws Until Reaching $10/Share or 30 Trading Days (GlobeNewswire) +19.50%
Mar-18-25 08:05AM SCIENTURE announces the U.S. FDA Approval of its NDA for SCN-102, to be launched as ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL. The global market for losartan potassium was approximately $1.5 billion in sales in 2024. (GlobeNewswire) -35.89%
Mar-06-25 07:40AM SCIENTURE to commercially launch REZENOPY , a life-saving opioid overdose emergency treatment through a collaboration with KINDEVA DRUG DELIVERY L.P. (GlobeNewswire) +9.55%
Jan-21-25 08:05AM Scienture Holdings, Inc. Announces Dr. Narasimhan Mani's Participation in the 8th Annual Conference of The Society for the Study of Xenobiotics (GlobeNewswire)
Dec-17-24 08:05AM Scienture Holdings, Inc. Announces Participation in The Microcap Conference 2025 (GlobeNewswire)
Dec-10-24 08:05AM Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041 (GlobeNewswire) +6.48%
Nov-26-24 04:05PM Scienture Holdings, Inc. Announces Private Placement of $3 Million of 10% Secured Convertible Debentures as Initial Tranche of $12 Million Offering and Entry into $50 Million Equity Line of Credit Agreement (GlobeNewswire) -5.37% +8.02%
Sep-24-24 08:01AM TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to SCNX (GlobeNewswire)
Sep-20-24 11:59AM TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. (GlobeNewswire)
Aug-05-24 08:01AM TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC's Executive Leadership Team (GlobeNewswire) -15.66%
Scienture Holdings, Inc. engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.
GRI - GRI Bio Inc - Stock Price Chart
TickerGRI [NASD]
CompanyGRI Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap4.34MEPS (ttm)-203.36
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y70.23%
P/S-EPS next 5Y-
P/B1.08EPS Q/Q98.93%
Dividend-Sales Q/Q-
Insider Own0.05%Inst Own2.51%
Insider Trans0.00%Inst Trans-
Short Float5.17%EarningsFeb 26
Analyst Recom1.00Target Price170.00
Avg Volume12.79K52W Range5.12 - 183.43
GRI Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis. The company was founded by Vipin Kumar Chaturvedi in May 2009 and is headquartered in La Jolla, CA.
UAMY - United States Antimony Corp - Stock Price Chart
TickerUAMY [AMEX]
CompanyUnited States Antimony Corp
CountryUSA
IndustryOther Industrial Metals & Mining
Market Cap241.87MEPS (ttm)-0.02
P/E-EPS this Y300.00%
Forward P/E7.15EPS next Y637.50%
PEG-EPS past 5Y21.57%
P/S16.19EPS next 5Y-
P/B8.34EPS Q/Q75.53%
Dividend-Sales Q/Q312.66%
Insider Own23.72%Inst Own20.14%
Insider Trans1.19%Inst Trans10.43%
Short Float12.01%EarningsMar 20/b
Analyst Recom1.00Target Price2.78
Avg Volume2.25M52W Range0.21 - 2.35
Mar-21-25Initiated B. Riley Securities Buy $3
United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
EVANS GARY CChairman & CEODec 10 '24Buy1.45200,000289,4001,528,818Dec 11 04:40 PM
MCMANUS MICHAEL A JRDirectorDec 10 '24Buy1.4670,000102,060338,333Dec 11 12:25 PM
MCMANUS MICHAEL A JRDirectorNov 18 '24Buy0.5650,00028,250268,333Nov 19 03:44 PM
ISAAK RICHARD RSVP, Chief Financial OfficerSep 09 '24Buy0.695,0003,44571,667Sep 10 09:50 AM
Hubert RachelControllerAug 15 '24Buy0.457,5003,3727,500Aug 19 01:29 PM
SNWV - Sanuwave Health Inc - Stock Price Chart
TickerSNWV [NASD]
CompanySanuwave Health Inc
CountryUSA
IndustryMedical Devices
Market Cap321.51MEPS (ttm)-7.67
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y18.26%
P/S9.85EPS next 5Y-
P/B-EPS Q/Q-124.88%
Dividend-Sales Q/Q47.64%
Insider Own3.79%Inst Own28.29%
Insider Trans0.00%Inst Trans0.92%
Short Float0.52%Earnings-
Analyst Recom-Target Price0.75
Avg Volume11.48K52W Range4.28 - 32.40
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.
AUID - authID Inc - Stock Price Chart
TickerAUID [NASD]
CompanyauthID Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap80.60MEPS (ttm)-1.46
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y22.64%
P/S90.56EPS next 5Y-
P/B7.00EPS Q/Q-42.66%
Dividend-Sales Q/Q177.81%
Insider Own15.94%Inst Own15.47%
Insider Trans0.57%Inst Trans8.65%
Short Float2.98%EarningsMar 13/a
Analyst Recom-Target Price-
Avg Volume41.40K52W Range4.01 - 12.31
authID, Inc. engages in the delivery of secure, mobile, and biometric identity solutions. It operates through the Verified Authentication Business segment. The company was founded by Thomas R Snoke on September 21, 2011 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Szoke Thomas RobertChief Technology OfficerDec 11 '24Sale6.341,0006,34015,518Dec 12 08:00 AM
Szoke Thomas RobertChief Technology OfficerDec 10 '24Sale6.301,0006,30016,518Dec 12 08:00 AM
Thompson Michael CharlesDirectorDec 10 '24Buy6.495,00032,46283,677Dec 11 08:05 AM
Szoke Thomas RobertChief Technology OfficerDec 06 '24Sale6.251,5009,38117,518Dec 10 05:27 PM
Jisser KenDirectorDec 09 '24Buy6.488,00051,84051,475Dec 10 08:01 AM
NAYA - NAYA Biosciences - Stock Price Chart
TickerNAYA [NASD]
CompanyNAYA Biosciences
CountryUSA
IndustryMedical Devices
Market Cap1.82MEPS (ttm)-30.54
P/E-EPS this Y74.85%
Forward P/E-EPS next Y84.50%
PEG-EPS past 5Y17.42%
P/S0.32EPS next 5Y62.52%
P/B-EPS Q/Q79.67%
Dividend-Sales Q/Q481.38%
Insider Own15.56%Inst Own2.55%
Insider Trans0.00%Inst Trans-
Short Float1.49%EarningsNov 11
Analyst Recom1.00Target Price24.00
Avg Volume23.62K52W Range1.94 - 42.00
Mar-13-25 04:30PM NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025 (GlobeNewswire) -33.76%
Feb-25-25 08:00AM NAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility Treatment (GlobeNewswire) -6.33%
Feb-19-25 09:15AM NAYA Biosciences Announces Nomination of New Board Members (GlobeNewswire)
Jan-13-25 09:15AM NAYA Biosciences Announces Pricing of $9.5 Million Public Offering (GlobeNewswire) -38.53%
Jan-06-25 08:30AM NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody (GlobeNewswire) +9.74%
Oct-31-24 09:00AM NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC) (GlobeNewswire)
Oct-24-24 09:00AM NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma (GlobeNewswire)
Oct-21-24 09:00AM INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences (GlobeNewswire)
Oct-14-24 09:18AM INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA) (GlobeNewswire) +89.31%
Aug-14-24 09:00AM INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA (GlobeNewswire)
NAYA Biosciences, Inc. operates a revenue-generating fertility business. It also focuses on the development of class clinical-stage assets in oncology and autoimmune diseases. The company was founded on October 14, 2024 and is headquartered in Sarasota, FL.
123456781020